Vaccines for inactivating the coronavirus being tested at China National Pharmaceutical Group (Sinopharm) in Beijing on April 11, 2020. Photo: Xinhua Vaccines for inactivating the coronavirus being tested at China National Pharmaceutical Group (Sinopharm) in Beijing on April 11, 2020. Photo: Xinhua
Vaccines for inactivating the coronavirus being tested at China National Pharmaceutical Group (Sinopharm) in Beijing on April 11, 2020. Photo: Xinhua
IPO
Business /  Companies

Tigermed roars in its Hong Kong stock trading debut, as Asia’s largest health care IPO of 2020 draws traders to its clinical trials

  • Clinical trial and research firm’s secondary listing was the biggest in Asia this year
  • Will use funds to expand overseas

Topic |   IPO
Deb Price
Deb Price

Updated: 10:52pm, 7 Aug, 2020

Why you can trust SCMP
Vaccines for inactivating the coronavirus being tested at China National Pharmaceutical Group (Sinopharm) in Beijing on April 11, 2020. Photo: Xinhua Vaccines for inactivating the coronavirus being tested at China National Pharmaceutical Group (Sinopharm) in Beijing on April 11, 2020. Photo: Xinhua
Vaccines for inactivating the coronavirus being tested at China National Pharmaceutical Group (Sinopharm) in Beijing on April 11, 2020. Photo: Xinhua
READ FULL ARTICLE